Prediction of protein–ligand binding modes is a key step in computer-aided drug design, since incorrect pose prediction inevitably limits the achievable accuracy of downstream physics-based affinity predictions. The ASAP-Polaris-OpenADMET antiviral competition was launched in 2025 as a means to prospectively test computational methods across a range of measurements that guide early prioritization during a drug discovery campaign including pose prediction. Here, we describe our two open-source, physics-based entries to the pose prediction challenge, which are based on templated molecular growth with hybrid machine learning/molecular mechanics interatomic potentials. We show that our approach was among the top-performing physics-based methods, and with a retrospective change to the workflow to make greater use of the training data as templates, we obtain a success rate of 74% across SARS-CoV-2 and MERS-CoV main protease target protein structures. Finally, we investigate the importance of receptor side-chain flexibility on retrospective performance. We find that building poses against an ensemble of feasible side-chain conformers is useful in generating improved binding poses but that the tested scoring functions are unable to successfully pick out native structures from the generated ensemble.
No takes yet. Share an insight, caveat, or question.
Khoualdi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: